A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemiaEsther Onecha, Rosa Ayala, María Linares et al.|Haematologica|2018Cited by 51
Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromesMaría‐Teresa Cedena, Joaquín Martínez‐López, Fernando Ramos et al.|Oncotarget|2017Cited by 43
Monitoring of clonal evolution of acute myeloid leukemia identifies the leukemia subtype, clinical outcome and potential new drug targets for post-remission strategies or relapseEsther Onecha, Rosa Ayala, Inmaculada Rapado et al.|Haematologica|2020Cited by 35
Clinical Utility of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia DiagnosticsCarmen Alonso, Eva Barragán, Marta Llop et al.|Journal of Molecular Diagnostics|2018Cited by 33
A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristicsRicardo Sánchez, Joaquín Martínez‐López, Jordi Ribera et al.|Blood Cancer Journal|2020Cited by 23